Figure 6
From: A validated prognostic nomogram for patients with H3 K27M-mutant diffuse midline glioma
Nomogram to predict the survival rate of patients with H3 K27M-mt DMG at 6, 12, and 18 months.
Figure 6 | Scientific Reports
From: A validated prognostic nomogram for patients with H3 K27M-mutant diffuse midline glioma
Nomogram to predict the survival rate of patients with H3 K27M-mt DMG at 6, 12, and 18 months.
